Related Experiment Video
Updated: Jan 7, 2026

Extraction and Analysis of Taiwanese Green Propolis
Published on: January 7, 2019
Phenolic compounds and bioactive peptides from Prosopis pod flours inhibit molecular markers of type 2 diabetes
Luis Mojica1, Maria Angeles Camacho-Ruíz2, Rosa Maria Camacho-Ruíz3
1Tecnología Alimentaria, Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco, AC, Guadalajara, México.
Background:
Prosopis is distributed across various regions of Mexico. Its pods are underutilized, as they are not commonly consumed. Studies on the pods' flour have demonstrated high content of sugars, fiber, and proteins, while lacking starch and gluten. Given these properties, there is interest in characterizing peptides and phenolic compounds in Prosopis flour that may inhibit enzymes associated with type 2 diabetes.
Results:
Six peptides ranging from six to nine amino acids were identified in protein hydrolysates from Prosopis pods. These peptides exhibited antioxidant activity, with an IC50 value of 1.13 mg mL-1 in DPPH, and inhibitory activity against α-glucosidase, a key enzyme in type 2 diabetes, with an IC50 of 5.86 mg mL-1. Docking analysis revealed that SAGHALA peptide had a binding energy of -31.7 kJ mol-1 with α-amylase. Phenolic compounds identified in methanolic extracts included rosmarinic, ferulic, p-coumaric, gallic, and ellagic acids; as well as naringenin, malvidin, petunidin, delphinidin, and rutin. Pigmented pods contained anthocyanins (13.58 g cyanidin-3-glucoside equivalents kg-1) and tannins (9.35 g catechin equivalents kg-1). Methanolic extracts from both pigmented and non-pigmented Prosopis pods exhibited inhibitory activity against α-glucosidase, with IC50 values of 1.05 and 0.74 mg mL-1, respectively. Among the phenolic compounds, naringenin exhibited the lowest predicted binding energy (-36.8 kJ mol-1) for α-amylase.
Conclusion:
Although Prosopis pods are not commonly consumed, their flour exhibits potential as a functional ingredient due to its high content of phenolic compounds and proteins. The phenolic compounds and bioactive peptides in Prosopis pods demonstrated inhibitory effects on molecular targets associated with type 2 diabetes. © 2025 Society of Chemical Industry.
Related Concept Videos
Dipeptidyl Peptidase 4 Inhibitors
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...

